Current Approaches for the Management of Multiple Sclerosis - A Review

被引:1
|
作者
Singh, Lakhwinder [1 ]
Yasmin, Sabina [1 ]
Sharma, Rajiv [1 ]
机构
[1] Chandigarh Univ, Univ Inst Pharma Sci, Mohali, India
关键词
Multiple sclerosis; autoimmune; DMTs; herbal plants; DIAGNOSIS; PATHOGENESIS; THERAPY;
D O I
10.9734/JPRI/2021/v33i52B33620
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Multiple sclerosis (MS) is an autoimmune, neuroinflammatory disease which interfere with the central nervous system and damage the myelin sheath and axons. It is mediated by auto-reactive lymphocytes that cross the blood brain barrier cause inflammation, demyelination and axonal loss disturb the communications between the neurons. The exact cause of the MS is not known but it is reported that it may be due to the genetic, environmental factors, viral infections (Epstein Barr virus). There are various approaches for the management of Multiple sclerosis like disease modifying agents are mainly used. Some of the monoclonal antibodies (Ocrelizumab) are approved recently for the management of MS. Due to various unwanted side effects with conventional medicines people are eager to use cost effective medicines with no or less side effects; therefore herbal medicines are best choice for them, they works by different pharmacological actions like reduce oxidative stress, anti-inflammatory, antioxidant effects and others. Mainly used herbal plants like Ginkgobiloba, Salvia officinalis, Nigella sativa.
引用
收藏
页码:222 / 228
页数:7
相关论文
共 50 条
  • [1] Multiple sclerosis treatments a review of current biomedical engineering approaches
    Mohseni, Sayyed Ourmazd
    Au, Kin Man
    Issa, Wadih
    Ruan, Lifu
    Stuve, Olaf
    Wang, Andrew Z.
    BIOMATERIALS, 2025, 313
  • [2] Pharmacological management of symptoms in multiple sclerosis: current approaches and future directions
    Thompson, Alan J.
    Toosy, Ahmed T.
    Ciccarelli, Olga
    LANCET NEUROLOGY, 2010, 9 (12): : 1182 - 1199
  • [3] Current approaches to the identification and management of breakthrough disease in patients with multiple sclerosis
    Rudick, Richard A.
    Polman, Chris H.
    LANCET NEUROLOGY, 2009, 8 (06): : 545 - 559
  • [4] Current management of multiple sclerosis
    Leary, SM
    Thompson, AJ
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2000, 54 (03) : 161 - 169
  • [5] New approaches in the management of multiple sclerosis
    Barten, Laurie J.
    Allington, Douglas R.
    Procacci, Kendra A.
    Rivey, Michael P.
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2010, 4 : 343 - 366
  • [6] Multiple Sclerosis Management: Current Clinical Approaches to Disease-Modifying Therapy
    Appleberry, Holly C.
    Shin, Robert K.
    CURRENT PHYSICAL MEDICINE AND REHABILITATION REPORTS, 2022, 10 (03) : 140 - 144
  • [7] Multiple Sclerosis Management: Current Clinical Approaches to Disease-Modifying Therapy
    Holly C. Appleberry
    Robert K. Shin
    Current Physical Medicine and Rehabilitation Reports, 2022, 10 : 140 - 144
  • [8] THE CURRENT MANAGEMENT OF MULTIPLE-SCLEROSIS
    SCHAPIRO, RT
    VANDENNOORT, S
    SCHEINBERG, L
    ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1984, 436 (DEC) : 425 - 434
  • [9] Novel Immunomodulatory Approaches for the Management of Multiple Sclerosis
    Kantarci, O. H.
    Pirko, I.
    Rodriguez, M.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2014, 95 (01) : 32 - 44
  • [10] Classification and management of sexual dysfunctions in multiple sclerosis patients: A review of current literature
    Campetella, Marco
    Marino, Filippo
    Gavi, Filippo
    Gandi, Carlo
    Ragonese, Mauro
    Coluzzi, Simone
    Racioppi, Marco
    Sacco, Emilio
    Bientinesi, Riccardo
    UROLOGIA JOURNAL, 2023, 90 (04) : 605 - 610